1. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. Issue 11 (November 2021) Authors: Bancroft, Elizabeth K; Page, Elizabeth C; Brook, Mark N; Thomas, Sarah; Taylor, Natalie; Pope, Jennifer; McHugh, Jana; Jones, Ann-Britt; Karlsson, Questa; Merson, Susan; Ong, Kai Ren; Hoffman, Jonathan; Huber, Camilla; Maehle, Lovise; Grindedal, Eli Marie; Stormorken, Astrid; Evans, D Gareth; Rot... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. (January 2020) Authors: Murray, Julia; Griffin, Clare; Gulliford, Sarah; Syndikus, Isabel; Staffurth, John; Panades, Miguel; Scrase, Christopher; Parker, Chris; Khoo, Vincent; Dean, Jamie; Mayles, Helen; Mayles, Philip; Thomas, Simon; Naismith, Olivia; Baker, Angela; Mossop, Helen; Cruickshank, Clare; Hall, Emma; Dearna... Journal: Radiotherapy and oncology Issue: Volume 142(2020) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Considering benefit and risk before routinely recommending SpaceOAR. Issue 1 (January 2021) Authors: Hall, William A; Tree, Alison C; Dearnaley, David; Parker, Christopher C; Prasad, Vinay; Roach, Mack; Lawton, Colleen A F Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 8 (August 2016) Authors: Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial. (March 2020) Authors: Murray, Julia; Gulliford, Sarah; Griffin, Clare; Wilkins, Anna; Syndikus, Isabel; Staffurth, John; Panades, Miguel; Scrase, Christopher; Parker, Chris; Khoo, Vincent; Dean, Jamie; Mayles, Helen; Mayles, Philip; Thomas, Simon; Naismith, Olivia; Mossop, Helen; Cruickshank, Clare; Hall, Emma; Dearna... Journal: Clinical and translational radiation oncology Issue: Volume 21(2020) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer. (4th October 2015) Authors: Wilkins, Anna; Dearnaley, David; Somaiah, Navita Other Names: Buonaguro Franco M. Academic Editor. Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Geometric and dosimetric evaluation of the differences between rigid and deformable registration to assess interfraction motion during pelvic radiotherapy. (January 2019) Authors: White, Ingrid; McQuaid, Dualta; McNair, Helen; Dunlop, Alex; Court, Steven; Hopkins, Naomi; Thomas, Karen; Dearnaley, David; Bhide, Shree; Lalondrelle, Susan Journal: Physics and imaging in radiation oncology Issue: Volume 9(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. How will the CHHiP trial affect the future of prostate radiotherapy?. Issue 7 (3rd July 2018) Authors: Dearnaley, David; Hall, Emma Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 7(2018) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hypofractionated radiotherapy for prostate cancer – Authors' reply. Issue 12 (December 2016) Authors: Dearnaley, David; Hall, Emma Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: e518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 16 (December 2015) Authors: Wilkins, Anna; Mossop, Helen; Syndikus, Isabel; Khoo, Vincent; Bloomfield, David; Parker, Chris; Logue, John; Scrase, Christopher; Patterson, Helen; Birtle, Alison; Staffurth, John; Malik, Zafar; Panades, Miguel; Eswar, Chinnamani; Graham, John; Russell, Martin; Kirkbride, Peter; O'Sullivan, Joe ... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗